Sunday, June 1, 2025

Latest

WELL Health Reports $25.6 Million In Revenue For Q1, Net Loss

WELL Health Technologies (TSX: WELL) this morning reported its first quarter 2021 financial results, reporting $25.6 million in revenue for the period along with a net loss of $7.1 million, or a loss of $0.04 per share. On an adjusted EBITDA basis, the company generated just $0.5 million in positive EBITDA.

Revenue for the period was reportedly a record on a quarterly basis, with revenues increasing 150% on a year over year basis from Q1 2020’s revenue of $10.2 million, and an improvement from the $17.2 million recognized in the fourth quarter. With a cost of sales of $15.5 million for the quarter, “adjusted” gross margins came in at 39.3%, with unadjusted numbers not yet filed by the company.

Notably, while the company technically hit its guidance of adjusted EBITDA improving for its Canadian operations, which saw the figure rise to $1.1 million from $417,000 in the fourth quarter, the company posted declining adjusted EBITDA on an overall quarter over quarter basis. The fourth quarter saw $765,000 in adjusted EBITDA, while the current quarter saw just $527,000.

In terms of outlook, the company remains persistent that it will achieve an annualized revenue run rate of $300 million, much of which is to come from the recently acquired CRH Medical. The company has also stated it is committed to achieving organic growth, continue with acquisitions, grow EBITDA, increase operating cash flows, and increase the market share of its digital health products.

WELL Health last traded at $7.31 on the TSX.


Information for this briefing was found via Sedar and WELL Health Technologies Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Well Health Posts Q4 Revenues Of $115.7 Million, Positive Net Income

Well Health (TSX: WELL) this morning reported its fourth quarter financial results, posting Q4 revenues...

Thursday, March 31, 2022, 08:04:20 AM

Well Health Begins Offering Direct To Consumer COVID-19 Antibody Tests In Ontario

Well Health Technologies (TSX: WELL) is getting on the COVID-19 testing trend. The company this...

Thursday, December 3, 2020, 08:17:28 AM

Well Health Acquires Majority Stake In US-Based Circle Medical For US$14.0 Million

Well Health Technologies (TSX: WELL) this morning announced that it is moving into the US...

Tuesday, September 1, 2020, 08:24:48 AM

Well Health To Raise $65.0 Million Via Convertible Debt

Well Health Technologies (TSX: WELL) is returning to the trough just days after reporting its...

Tuesday, November 16, 2021, 08:25:55 AM

Well Health Claims Record Revenues In May, Provides No Hard Details

Well Health Technologies (TSX: WELL) this morning attempted to rally its base amidst its endless...

Friday, June 10, 2022, 08:07:33 AM